Copyright
©2010 Baishideng.
World J Gastroenterol. Aug 14, 2010; 16(30): 3853-3856
Published online Aug 14, 2010. doi: 10.3748/wjg.v16.i30.3853
Published online Aug 14, 2010. doi: 10.3748/wjg.v16.i30.3853
Figure 1 Contrast-enhanced computed tomography scan of the abdomen.
A: There was a low-density mass, 7.5 cm in diameter, in the head of the pancreas at the time of admission. The pancreatic tumor (arrows) did not show contrast enhancement; B: A follow-up computed tomography scan showed that the pancreatic mass had reduced to 2.0 cm in diameter. The tumor (arrows) had markedly regressed 4 mo after starting chemotherapy with gemcitabine.
- Citation: Nakazuru S, Yoshio T, Suemura S, Itoh M, Araki M, Yoshioka C, Ohta M, Sueyoshi Y, Ohta T, Hasegawa H, Morita K, Toyama T, Kuzushita N, Kodama Y, Mano M, Mita E. Poorly differentiated endocrine carcinoma of the pancreas responded to gemcitabine: Case report. World J Gastroenterol 2010; 16(30): 3853-3856
- URL: https://www.wjgnet.com/1007-9327/full/v16/i30/3853.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i30.3853